Mammographic density tops list of breast cancer risk factors shaping Malaysia's rising cancer burden

MALAYSIA, 26 SEPTEMBER 2026 —

Breast cancer is rising quickly in Malaysia, and for the first time researchers have produced a detailed, population-specific accounting of just how much of that burden can be traced to individual risk factors.

The results offer the kind of locally grounded evidence that high-income countries have long relied upon to shape their cancer control strategies, but which has been largely missing for Southeast Asian populations. The headline finding is striking: mammographic density, a measure of the amount of fibroglandular tissue visible on a mammogram relative to fatty tissue, accounts for 32.8 percent of the breast cancer burden among Malaysian women.

That makes dense breasts the single largest contributor to the country’s breast cancer tally, outweighing every modifiable and hereditary factor examined in the study. The measurement matters because dense tissue both raises cancer risk independently and can mask tumors on mammographic images, complicating early detection in the very screening programs designed to catch the disease.

Among the factors that women and policymakers can actually change, elevated body mass index emerged as the leading contributor, responsible for 14.7 percent of the burden. Passive smoking accounted for another 8 percent. Together, these modifiable risks represent a substantial reservoir of preventable disease, and they respond to interventions ranging from weight management programs to smoke-free environment policies.

The emphasis on passive smoking is particularly notable in Malaysia, where direct smoking rates among women have historically been low, but exposure to secondhand smoke in households and public spaces remains common. Family history and genetic factors, which cannot be altered, collectively contributed 12.1 percent of the breast cancer burden.

While this share is smaller than that of mammographic density, it remains clinically significant because inherited risk concentrates in identifiable families, making it a natural target for genetic counseling, testing programs, and intensified surveillance. The figure aligns with a growing body of work showing that hereditary factors, including pathogenic variants in established breast cancer risk genes, play a meaningful role in Asian populations just as they do in European-descended populations.

The methodology behind these estimates reflects a deliberate effort to ground the analysis in Malaysian realities rather than importing figures from Western cohorts. The researchers calculated population attributable risk using Malaysia-specific prevalence data drawn from national surveys, including the National Health and Morbidity Survey, and from local epidemiological studies.

For the risk side of the equation, they used relative risks derived from meta-analyses of Asian prospective cohorts and case-control studies rather than relying on estimates from predominantly European populations. This dual commitment to local prevalence and Asian-specific effect sizes distinguishes the study from earlier attributable risk calculations in Japan, China, Korea, and Singapore that informed the broader literature.

Technically, the team estimated attributable proportions using Levin’s formula, a classic epidemiological expression that combines the prevalence of a risk factor in a population with the relative risk it confers. Because risk factors do not act in isolation, the researchers adjusted for the joint effects of multiple factors using a multiplicative model, the standard approach for combining independent risks without double counting.

To attach uncertainty to the resulting estimates, they generated simulation-based confidence intervals, a technique that repeatedly resamples from the distributions of prevalence and relative risk to produce a range for each attributable fraction. The overall framework echoes the methods used in comparable national assessments, including studies of attributable cancer causes in Japan, Korea, China, and Singapore, but with prevalence inputs tailored specifically to Malaysian women.

One of the most consequential insights from the analysis is how the dominant risk factors shift across the life course. Reproductive factors, such as parity and related hormonal history, play a pronounced role in breast cancer occurring before menopause, whereas elevated body mass index predominates after menopause. This pattern is consistent with the biology of breast cancer.

In premenopausal women, adipose tissue contributes relatively little to circulating estrogen compared with the ovaries, so reproductive history exerts a stronger influence. After menopause, when ovarian estrogen production ceases, fat tissue becomes the principal estrogen source, and excess body weight translates into elevated risk. The findings suggest that prevention messages should be age-calibrated: reproductive and lifestyle counseling for younger women, weight-focused interventions for older ones. Ethnicity adds a further layer of complexity.

Malaysia’s population comprises large Malay, Chinese, and Indian communities, and the study found that the impact of individual risk factors varies across these groups. Mammographic density was most influential among Chinese women, while elevated body mass index played a greater role among Malays and Indians. This uneven distribution has practical implications for screening and prevention.

Previous work by some of the same research groups has documented ethnic differences in mammographic density patterns across Asian populations, and the new attributable risk estimates translate those biological differences into consequences for the overall disease burden. The authors argue that these findings support a balanced approach to breast cancer control that combines targeted prevention with risk-based early detection tailored to age and ethnic differences.

In practice, that could mean prioritizing weight management and reducing secondhand smoke exposure as public health measures, while also building screening pathways that account for the high prevalence of dense breasts, particularly among Chinese Malaysian women.

It also reinforces the case for personalized or risk-stratified screening, an approach championed in international consensus statements such as the ENVISION framework, in which screening intensity and modalities are matched to an individual’s composite risk profile rather than applied uniformly by age alone. With breast cancer incidence climbing rapidly in Malaysia, the study fills a critical evidence gap.

Large prospective studies in high-income countries have long enabled the estimation of preventable cancer cases and guided national cancer control strategies, but locally relevant data have been scarce for Malaysia.

Related: Malaysia